Mezomax Inc.

Mezomax a preclinical orthopedics focused company developing a small molecule drug to accelerate osteogenesis in fractures, osteoporosis and rare bone diseases.

  • Stage Prototype Ready
  • Industry Biotechnology
  • Location San Francisco, CA, USA
  • Currency USD
  • Founded December 2017
  • Employees 5
  • Incorporation Type C-corp
  • Website mezomaxinc.com

Only investors on Gust who have been granted access can view this content.

Interested in this startup? Sign In or Sign Up to request more information.

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free